WMT
55
-4
HP
41
3
MHK
45
2
APD
50
5
CAG
34
-2
ETR
49
2
STX
64
-5
NTAP
56
-3
THC
48
2
CMCSA
50
6
PEG
50
4
MO
54
3
PRU
60
-2
DHR
68
2
AA
82
5
KO
46
2
LB
33
2
SBUX
40
-4
CA
21
-9
PVH
30
-2
WMT
55
-4
HP
41
3
MHK
45
2
APD
50
5
CAG
34
-2
ETR
49
2
STX
64
-5
NTAP
56
-3
THC
48
2
CMCSA
50
6
PEG
50
4
MO
54
3
PRU
60
-2
DHR
68
2
AA
82
5
KO
46
2
LB
33
2
SBUX
40
-4
CA
21
-9
PVH
30
-2
Financhill
Back

Goldman Sachs Nasdaq-100 Premium Income ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
61

GPIQ
Goldman Sachs Nasdaq-100 Premium Income ETF

Last Price:
$53.38
Seasonality Move:
-2.79%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
61
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) is a Buy

Is Goldman Sachs Nasdaq-100 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Nasdaq-100 Premium Income ETF [GPIQ] share price is $53.16. The Score for GPIQ is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPIQ Stock Price Chart

What is Goldman Sachs Nasdaq-100 Premium Income ETF's stock price today?

  • The Goldman Sachs Nasdaq-100 Premium Income ETF share price today is $53.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIQ is experiencing slight selling pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

GPIQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 54.12 Buy
Chaikin Money Flow: -295851 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.79 - 53.35) Buy
Bollinger Bands (100): (50.88 - 53.18) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

GPIQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.62 Buy
20-day SMA: 52.88 Buy
50-day SMA: 52.81 Buy
200-day SMA: 49.39 Buy
8-day EMA: 52.73 Buy
20-day EMA: 52.75 Buy
50-day EMA: 52.57 Buy
200-day EMA: 50.54 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Goldman Sachs Nasdaq-100 Premium Income ETF Earnings Growth & GPIQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Goldman Sachs Nasdaq-100 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):